Abstract P5-12-09: Patient-reported outcomes (PROs) during one year of adjuvant enzalutamide for the treatment of early stage androgen receptor positive (AR+) triple negative breast cancer
暂无分享,去创建一个
M. Robson | L. Jones | T. Traina | Jessica M. Scott | S. Patil | A. Gucalp | V. Blinder | Artavazd Arumov | P. Defusco | L. Boyle | N. Lamparella | Tina Alano